Evidence map›Paper›PMID 28250055›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Mapping the Hypocretin/Orexin Neuronal System: An Unexpectedly Productive Journey.

Christelle Peyron, Thomas S Kilduff

Open access · bronzeAbstract readHistorical Article
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Heterogeneity of Hypocretin/Orexin Neurons.Frontiers of neurology and neuroscience · 2021
    Review
  10. Chemogenetic activation of orexin/hypocretin neurons ameliorates aging-induced changes in behavior and energy expenditure.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Christelle PeyronCenter for Research in Neuroscience of Lyon, Sleep team, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5292, Institut National de la Santé et de la Recherche Médicale U1028, Université Claude Bernard Lyon 1, Lyon, France, and peyron@sommeil.univ-lyon1.fr.
Thomas S KilduffCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, California 94025.
Inserm · FRSRI International · US

Funding

U.S.-Japan BRCP Supplement to "The Tuberal Hypothalamus and Arousal State Control"R01NS098813 · NINDS · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2016 to 2020
$3.3M
Travel support for U.S.-Japan Brain Research Colllaborative ProgramR01NS077408 · NINDS · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2012 to 2016
$2.2M
NINDS NIH HHS R01 NS077408NINDS NIH HHS R01 NS098813
6 · The paper itself

Abstract

Early in 1998, we (de Lecea et al., 1998) and others (Sakurai et al., 1998) described the same hypothalamic neuropeptides, respectively called the hypocretins or orexins, which were discovered using two different approaches. In December of that year, we published the subject of this commentary in the

Indexed as

Periodicals as TopicAnimalsBrainHistory, 20th CenturyHistory, 21st CenturyHumansNeuronsNeurosciencesOrexinsOrexins

Identifiers

PMID28250055
PMCPMC5354341
OpenAlexW2592581171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.